PARKINSON'S DISEASE QUESTIONNAIRE (PDQ-39) AS A PRIMARY ENDPOINT IN A TRIAL COMPARING DEEP BRAIN STIMULATION WITH BEST MEDICAL THERAPY VERSUS BEST MEDICAL THERAPY ALONE FOR ADVANCED PARKINSON'S DISEASE (PD SURG TRIAL): A RANDOMISED, OPEN-LABEL TRIAL

被引：0
|
作者：
Jenkinson, C. [1 ]
Williams, A. [2 ]
Ives, N. [2 ]
Rick, C. [2 ]
Daniels, J. [2 ]
Patel, S. [2 ]
Wheatley, K. [2 ]
Churchman, D. [3 ]
机构：
[1] Univ Oxford, Hlth Serv Res Unit, Dept Publ Hlth, Oxford, England
[2] Univ Birmingham, PD SURG Collaborat Grp, PD SURG Trial Off, Birmingham, W Midlands, England
[3] Isis Innovat Ltd, Oxford, England
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
基金：
英国医学研究理事会;
关键词：
D O I：
10.1016/j.jval.2012.03.800
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A148 / A148
页数：1
相关论文
共 50 条
  • [41] Conversion from dopamine agonists to pramipexole: An open-label trial in 227 patients with advanced Parkinson's disease
    Linazasoro, G
    MOVEMENT DISORDERS, 2002, 17 : S66 - S66
  • [42] Conversion from dopamine agonists to pramipexoleAn open-label trial in 227 patients with advanced Parkinson’s disease
    G. Linazasoro
    Journal of Neurology, 2004, 251 : 335 - 339
  • [43] Conversion from dopamine agonists to pramipexole - An open-label trial in 227 patients with advanced Parkinson's disease
    Linazasoro, G
    JOURNAL OF NEUROLOGY, 2004, 251 (03) : 335 - 339
  • [44] Coversion from dopamine agonists to cabergoline: An open-label trial in 202 patients with advanced Parkinson's disease
    Linazasoro, GJ
    MOVEMENT DISORDERS, 2005, 20 : S68 - S68
  • [45] Protocol of a randomized open label multicentre trial comparing continuous intrajejunal levodopa infusion with deep brain stimulation in Parkinson's disease-the INfusion VErsus STimulation (INVEST) study
    van Poppelen, D.
    Sisodia, V.
    de Haan, R. J.
    Dijkgraaf, M. G. W.
    Schuurman, P. R.
    Geurtsen, G. J.
    Berk, A. E. M.
    de Bie, R. M. A.
    Dijk, J. M.
    BMC NEUROLOGY, 2020, 20 (01)
  • [46] Gene therapy for Parkinson's disease with AAV-GAD: An open-label, dose escalation, safety-tolerability trial
    Feigin, A
    Kaplitt, M
    During, M
    Strybing, K
    Cox, M
    Dhawan, V
    Eidelberg, D
    MOVEMENT DISORDERS, 2005, 20 (09) : 1236 - 1236
  • [47] Screening diabetic patients for unknown coronary disease. An open-label randomized trial comparing exercise testing aimed at revascularization with management based on best medical therapy
    Turrini, F.
    Messora, R.
    Giovanardi, P.
    Scarlini, S.
    Magnavacchi, P.
    Evandri, V.
    Zanasi, A.
    Cavani, R.
    Tondi, S.
    Bondi, M.
    EUROPEAN HEART JOURNAL, 2013, 34 : 637 - 637
  • [48] Chronic adaptive deep brain stimulation versus conventional stimulation in Parkinson's disease: a blinded randomized feasibility trial
    Oehrn, Carina R.
    Cernera, Stephanie
    Hammer, Lauren H.
    Shcherbakova, Maria
    Yao, Jiaang
    Hahn, Amelia
    Wang, Sarah
    Ostrem, Jill L.
    Little, Simon
    Starr, Philip A.
    NATURE MEDICINE, 2024, 30 (11) : 3345 - 3356
  • [49] Deep brain stimulation in early stage Parkinson's disease: operative experience from a prospective randomised clinical trial
    Kahn, Elyne
    D'Haese, Pierre-Francois
    Dawant, Benoit
    Allen, Laura
    Kao, Chris
    Charles, P. David
    Konrad, Peter
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 (02): : 164 - 170
  • [50] Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease: ADAPT-PD Trial: A Prospective Single-Blind, Randomized Crossover, Multi-Center Trial of Deep Brain Stimulation Adaptive Algorithms in Subjects with Parkinson's Disease
    Kuhn, A.
    Tonder, L.
    Raike, R.
    Stanslaski, S.
    Lynch, K.
    Bronte-Stewart, H.
    MOVEMENT DISORDERS, 2020, 35 : S404 - S404
12345